|
|
Article: BioSphere Medical Highlights Scheduled Presentations and Abstracts at the 2008 SIR 33rd Annual Scientific Meeting.
- Article from:
- Business Wire
- Article date:
- March 14, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ROCKLAND, Mass. -- BioSphere Medical, Inc. (NASDAQ: BSMD) today announced that a satellite symposium, podium presentations, and key abstracts related to the Company's embolic products for the treatment of symptomatic uterine fibroids, liver cancer and arteriovenous malformations have been accepted at the Society for Interventional Radiologists (SIR) 33rd Annual Scientific Meeting being held March 15-20, 2008 in Washington, D.C. BioSphere's booth number is 1213.
Richard Faleschini, BioSphere Medical's president and chief executive officer, said, "The SIR meeting is one of the premier annual events for interventional radiologists from around the world. Attending ...